Armata Pharmaceuticals to Present at the Ladenburg Thalmann 2021 Healthcare Conference
MARINA DEL REY, Calif., July 7, 2021 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, today announced that the Company will present and participate in one-on-one investor meetings at the Ladenburg Thalmann 2021 Healthcare Conference taking place July 13-14, 2021.
Presentation details can be found below.
Date: |
Tuesday, July 13, 2021 |
Time: |
4:00 PM ET |
Webcast Link: |
Armata is a clinical-stage biotechnology company focused on the development of precisely targeted bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. Armata is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, known as MSD outside of the United States and Canada, Armata is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent. Armata is committed to advancing phage with drug development expertise that spans bench to clinic including in-house phage specific GMP manufacturing.
Media Contacts:
At Armata:Steve MartinArmata Pharmaceuticals, Inc.[email protected]858-800-2492
Investor Relations:Joyce AllaireLifeSci Advisors, LLC[email protected]212-915-2569
View original content to download multimedia:https://www.prnewswire.com/news-releases/armata-pharmaceuticals-to-present-at-the-ladenburg-thalmann-2021-healthcare-conference-301326239.html
SOURCE Armata Pharmaceuticals, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nuventive and D2L Partner to Streamline Data-Informed Learning Outcomes Improvement
- Air Products to Broadcast Fiscal Second Quarter Earnings Teleconference on April 30, 2024
- Judd Foundation Statement on Clements Design Response to Lawsuit
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Ladenburg Thalmann Financial ServicesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!